These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 28601833)

  • 1. Targeted simplification versus antipseudomonal broad-spectrum beta-lactams in patients with bloodstream infections due to
    López-Cortés LE; Rosso-Fernández C; Núñez-Núñez M; Lavín-Alconero L; Bravo-Ferrer J; Barriga Á; Delgado M; Lupión C; Retamar P; Rodríguez-Baño J;
    BMJ Open; 2017 Jun; 7(6):e015439. PubMed ID: 28601833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and safety of a structured de-escalation from antipseudomonal β-lactams in bloodstream infections due to Enterobacterales (SIMPLIFY): an open-label, multicentre, randomised trial.
    López-Cortés LE; Delgado-Valverde M; Moreno-Mellado E; Goikoetxea Aguirre J; Guio Carrión L; Blanco Vidal MJ; López Soria LM; Pérez-Rodríguez MT; Martínez Lamas L; Arnaiz de Las Revillas F; Armiñanzas C; Ruiz de Alegría-Puig C; Jiménez Aguilar P; Del Carmen Martínez-Rubio M; Sáez-Bejar C; de Las Cuevas C; Martín-Aspas A; Galán F; Yuste JR; Leiva-León J; Bou G; Capón González P; Boix-Palop L; Xercavins-Valls M; Goenaga-Sánchez MÁ; Anza DV; Castón JJ; Rufián MR; Merino E; Rodríguez JC; Loeches B; Cuervo G; Guerra Laso JM; Plata A; Pérez Cortés S; López Mato P; Sierra Monzón JL; Rosso-Fernández C; Bravo-Ferrer JM; Retamar-Gentil P; Rodríguez-Baño J;
    Lancet Infect Dis; 2024 Apr; 24(4):375-385. PubMed ID: 38215770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In
    Ouranos K; Mylonakis E
    Ann Intern Med; 2024 May; 177(5):JC52. PubMed ID: 38710092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
    Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
    Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical efficacy of β-lactam/β-lactamase inhibitor combinations for the treatment of bloodstream infection due to extended-spectrum β-lactamase-producing Enterobacteriaceae in haematological patients with neutropaenia: a study protocol for a retrospective observational study (BICAR).
    Gudiol C; Royo-Cebrecos C; Tebe C; Abdala E; Akova M; Álvarez R; Maestro-de la Calle G; Cano A; Cervera C; Clemente WT; Martín-Dávila P; Freifeld A; Gómez L; Gottlieb T; Gurguí M; Herrera F; Manzur A; Maschmeyer G; Meije Y; Montejo M; Peghin M; Rodríguez-Baño J; Ruiz-Camps I; Sukiennik TC; Carratalà J;
    BMJ Open; 2017 Jan; 7(1):e013268. PubMed ID: 28115333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre randomised controlled trial to investigate usefulness of the rapid diagnostic βLACTA test performed directly on bacterial cell pellets from respiratory, urinary or blood samples for the early de-escalation of carbapenems in septic intensive care unit patients: the BLUE-CarbA protocol.
    Garnier M; Gallah S; Vimont S; Benzerara Y; Labbe V; Constant AL; Siami S; Guerot E; Compain F; Mainardi JL; Montil M; Quesnel C;
    BMJ Open; 2019 Feb; 9(2):e024561. PubMed ID: 30782909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of de-escalation therapy to ertapenem for treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae: an open-label randomized controlled trial.
    Rattanaumpawan P; Werarak P; Jitmuang A; Kiratisin P; Thamlikitkul V
    BMC Infect Dis; 2017 Mar; 17(1):183. PubMed ID: 28249572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EUropean prospective cohort study on
    Gutiérrez-Gutiérrez B; Sojo-Dorado J; Bravo-Ferrer J; Cuperus N; de Kraker M; Kostyanev T; Raka L; Daikos G; Feifel J; Folgori L; Pascual A; Goossens H; O'Brien S; Bonten MJ; Rodríguez-Baño J;
    BMJ Open; 2017 Apr; 7(4):e015365. PubMed ID: 28373258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.
    Rosso-Fernández C; Sojo-Dorado J; Barriga A; Lavín-Alconero L; Palacios Z; López-Hernández I; Merino V; Camean M; Pascual A; Rodríguez-Baño J;
    BMJ Open; 2015 Mar; 5(3):e007363. PubMed ID: 25829373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen).
    Bitterman R; Koppel F; Mussini C; Geffen Y; Chowers M; Rahav G; Nesher L; Ben-Ami R; Turjeman A; Huberman Samuel M; Cheng MP; Lee TC; Leibovici L; Yahav D; Paul M
    BMJ Open; 2021 Feb; 11(2):e040210. PubMed ID: 33558347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigator-Driven Randomised Controlled Trial of Cefiderocol versus Standard Therapy for Healthcare-Associated and Hospital-Acquired Gram-negative Bloodstream Infection: Study protocol (the GAME CHANGER trial): study protocol for an open-label, randomised controlled trial.
    Wright H; Harris PNA; Chatfield MD; Lye D; Henderson A; Harris-Brown T; Donaldson A; Paterson DL
    Trials; 2021 Dec; 22(1):889. PubMed ID: 34876196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial stewardship of β-lactams in intensive care units.
    Cotta MO; Roberts JA; Tabah A; Lipman J; Vogelaers D; Blot S
    Expert Rev Anti Infect Ther; 2014 May; 12(5):581-95. PubMed ID: 24655303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Empiric Monotherapy Versus Combination Therapy for Enterobacteriaceae Bacteremia in Children.
    Berkowitz NM; Spaeder MC; DeBiasi RL; Campos J; Singh N
    Pediatr Infect Dis J; 2015 Nov; 34(11):1203-6. PubMed ID: 26301498
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of De-escalation on Prognosis of Patients With Bacteremia due to Enterobacteriaceae: A Post Hoc Analysis From a Multicenter Prospective Cohort.
    Palacios-Baena ZR; Delgado-Valverde M; Valiente Méndez A; Almirante B; Gómez-Zorrilla S; Borrell N; Corzo JE; Gurguí M; De la Calle C; García-Álvarez L; Ramos L; Gozalo M; Morosini MI; Molina J; Causse M; Pascual Á; Rodríguez-Baño J;
    Clin Infect Dis; 2019 Aug; 69(6):956-962. PubMed ID: 30535051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for treatment failure in patients receiving β-lactam/β-lactamase inhibitor combinations for Enterobacteriaceae bloodstream infection: A retrospective, single-centre, cohort study.
    Giannella M; Pascale R; Ferraro G; Toschi A; Pancaldi L; Furii F; Bartoletti M; Tedeschi S; Ambretti S; Lewis RE; Viale P
    Int J Antimicrob Agents; 2019 May; 53(5):574-581. PubMed ID: 30639527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative Effect of an Antimicrobial Stewardship and Rapid Diagnostic Testing Bundle on Early Streamlining of Antimicrobial Therapy in Gram-Negative Bloodstream Infections.
    Bookstaver PB; Nimmich EB; Smith TJ; Justo JA; Kohn J; Hammer KL; Troficanto C; Albrecht HA; Al-Hasan MN
    Antimicrob Agents Chemother; 2017 Sep; 61(9):. PubMed ID: 28630187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quality of care indicators in the MAnageMent of BlOOdstream infections caused by Enterobacteriaceae (MAMBOO-E study): state of the art and research agenda.
    Giannella M; Malosso P; Scudeller L; Bussini L; Rebuffi C; Gatti M; Bartoletti M; Ianniruberto S; Pancaldi L; Pascale R; Tedeschi S; Viale P; Paul M
    Int J Antimicrob Agents; 2021 Apr; 57(4):106320. PubMed ID: 33716177
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care (the ASPIC trial): study protocol for a randomised controlled trial.
    Foucrier A; Roquilly A; Bachelet D; Martin-Loeches I; Bougle A; Timsit JF; Montravers P; Zahar JR; Eloy P; Weiss E;
    BMJ Open; 2023 Feb; 13(2):e065293. PubMed ID: 36810173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Risk Score for Prediction of Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates.
    Augustine MR; Testerman TL; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Infect Control Hosp Epidemiol; 2017 Mar; 38(3):266-272. PubMed ID: 27989244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. De-escalation of antimicrobials in the treatment of bacteraemia due to antibiotic-sensitive pathogens in immunocompetent patients.
    Shime N; Satake S; Fujita N
    Infection; 2011 Aug; 39(4):319-25. PubMed ID: 21509424
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.